The approved therapy Uplizna (inebilizumab) may reduce the risk of disease flares in adults with IgG4-related disease (IgG4-RD)…
Articles by Marisa Horak, MS
Certain immune cell markers appear to closely track disease activity in people with IgG4-related disease (IgG4-RD), a study by…
Obexelimab, an investigational therapy for people with immunoglobulin G4-related disease (IgG4-RD), was found to reduce disease activity among…
When starting treatment for IgG4-related disease (IgG4-RD), having measurements of certain immune cell levels may help doctors predict the…
In a proof-of-concept study, a team of scientists in Spain has identified a range of blood markers related to immune…
People with IgG4-related disease (IgG4-RD) who have very high levels of the antibody immunoglobulin G4 (IgG4) are more likely…
IgG4-related disease (IgG4-RD) can in some cases affect the voice box, causing symptoms such as voice changes and difficulty…
In a proof-of-concept clinical trial, the oral treatment candidate zanubrutinib was shown to reduce disease activity for 10 people…
Valerio Therapeutics is teaming up with Abivax to discover new treatments for immune-mediated inflammatory diseases. The deal will…
Glucocorticoid therapy alone is often not enough to manage rare cases of IgG4-related disease (IgG4-RD) that manifest with thickening…